Positron emission tomography (PET) using fluorine-18 deoxyglucose (FDG), showing
increased FDG uptake and retention in malignant cells, has been proven useful to …

Introduction: The prognostic value of quantitative 18F-fluoro-2-deoxy-d-glucose (FDG)
uptake on positron emission tomography (PET) is controversial in unselected patients with …

Introduction We compared primary non-small cell lung cancer (NSCLC) 18 F-
fluorodeoxyglucose (FDG) uptake at positron emission tomography (PET) to tumor histologic …

Introduction: A recent meta-analysis suggested that patients with non–small-cell lung cancer
(NSCLC) whose primary tumors have a higher standardized uptake value (SUV) derived …

Prognostic value of metabolic variables of [18F]FDG PET/CT i... : Medicine Prognostic value of
metabolic variables of [18F]FDG PET/CT in surgically resected stage I lung adenocarcinoma …

Purpose A retrospective review of surgically treated lung cancer patients imaged
preoperatively by F-18 fluorodeoxyglucose–positron emission tomography ([18F] FDG-PET) …

Positron emission tomography (PET) imaging using 18F-2-deoxy-D-glucose, a D-glucose
analog labeled with fluorine-18 (FDG-PET), is being evaluated in the assessment of …

Among patients with resected non–small cell lung cancer (NSCLC), approximately 50%
present with a recurrent tumor. The clinical or pathologic TNM staging does not always …

Many studies have shown that FDG uptake is related to prognosis of non-small cell lung
cancer, and metastasis is the major cause of death due to lung cancer patients. However …

PURPOSE: To prospectively study the impact of 18F fluorodeoxyglucose (FDG) positron
emission tomography (PET) on clinical management of patients with non–small-cell lung …